3.86700 EUR
0.149
3.71%
Last update Dec 12, 7:37 PM CET
Main market
Day range
3.86700
4.10600
Previous close
4.016000
Open
3.91700
Access this stock data via API
Subscribe
Aldeyra Therapeutics Inc.
3.87
0.15
3.71%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 4.6M 7.2M 6.3M 12.5M
Selling general and admin 2.2M 1.4M 2.6M 1.7M
Other operating expenses
Operating income -6.8M -8.7M -8.9M -14.1M
Non operating interest income
Income 671.8K 742.8K 836.0K 1.1M
Expense 405.4K 400.9K 411.9K 401.1K
Other income expense
Pretax income -6.5M -8.3M -8.5M -13.5M
Tax provision
Net income -6.5M -8.3M -8.5M -13.5M
Basic EPS -0.1 -0.2 -0.2
Diluted EPS -0.1 -0.2 -0.2
Basic average shares 51.2M 51.1M 51.0M
Diluted average shares 51.2M 51.1M 51.0M
EBITDA -6.1M -7.9M -8.0M -13.0M
Net income from continuing op. -6.5M -8.3M -8.5M -13.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 6 minutes

09:53
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).